Small molecule · Inhibitor of NLRP3 inflammasome sensor (NLRP3) (NLRP3) · developed by Olatec Therapeutics
Phase 1/2Most advanced trial
What is Dapansutrile?
Dapansutrile is an orally bioavailable small molecule that specifically binds to and inhibits NLRP3, the sensor of the NLRP3 inflammasome, preventing its formation. This reduces production of the pro-inflammatory cytokines IL-1beta and IL-18. It is being studied in melanoma.
Summary written with AI from the sources listed at the end of this page.
At a glance
Also known as
OLT-1177
Drug type
Small molecule
Targets
NLRP3 inflammasome sensor (NLRP3) (NLRP3)
Mechanism
Inhibitor of NLRP3 inflammasome sensor (NLRP3) (NLRP3)
Pathways
NLRP3 inflammasome formation, IL-1beta and IL-18 production
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.